The pathophysiological role of MiRNAs in heart failure
Frontiers in Cardiovascular Medicine · 03.06.2026 · 13
DOI: 10.3389/fcvm.2026.1753834 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 03.06.2026. Verfasst von Kun Lian und 9 weiteren Autor:innen. Beteiligte Einrichtung: Hunan University of Chinese Medicine, Changsha, China. Die Arbeit nennt 134 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institutes of Natural Sciences.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Background
Heart failure (HF) is a growing global health issue, chiefly marked by inexorable myocyte loss, maladaptive remodeling, and energetic failure. MicroRNAs (miRNAs) function as the principal post-transcriptional regulators of gene networks capable of facilitating the pathophysiology of illnesses. However, there is limited systemic-level understanding of their participation in human HF. Therefore, the miRNA mechanisms that modulate apoptosis, autophagy, myocardial fibrosis, inflammatory response, and energy metabolism of cardiomyocytes to inhibit and treat HF are elucidated in this work.
Method
A analysis of the mechanisms utilized by miRNAs in the modulation of HF was performed following the retrieval of literature on the mechanism of action of miRNAs in HF. The literature was obtained from PubMed and Web of Science databases between 2021 and 2025.
Result
The multi-dimensional regulatory function of miRNAs in HF was uncovered. At the cellular fate level, they mediate the survival and death of the myocardium and inhibit excessive apoptosis and oxidative damage. At the organizational structure level, they inhibit the advancement of pathological ventricular remodeling and fibrosis. At the energy homeostasis level, they control autophagy and energy metabolism of cells. Finally, at the inflammatory and signaling levels, they suppress the inflammatory storm and maintain calcium signaling homeostasis. A sophisticated and dynamic regulatory system consisting of various miRNAs was observed, which offers a theoretical basis and potential targets for HF mechanism research and targeted intervention.
Conclusion
MicroRNAs (miRNAs) jointly affect the survival, remodeling and energy balance of cardiac muscle cells. However, the clinical application of miRNAs in HF is still in the early exploration stage, and their true diagnostic value and therapeutic potential need to be further confirmed by rigorous and large-scale clinical studies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hunan University of Chinese Medicine, Changsha, China.
Förderung
- National Institutes of Natural Sciences
Zitieren
APA
Lian, K., Qi, Q., Meng, L., Zhu, X., Zhang, Y., Xu, Y., Song, Z., Li, L., Hu, S., & Hu, Z. (2026). The pathophysiological role of MiRNAs in heart failure. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1753834
Vancouver
Lian K, Qi Q, Meng L, Zhu X, Zhang Y, Xu Y, et al. The pathophysiological role of MiRNAs in heart failure. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1753834
BibTeX
@article{Lian2026,
author = {Lian, Kun and Qi, Qing and Meng, Lichong and Zhu, Xin and Zhang, Yubin and Xu, Yichang and Song, Zhiguang and Li, Lin and Hu, Siyuan and Hu, Zhixi},
title = {The pathophysiological role of MiRNAs in heart failure},
journal = {Frontiers in Cardiovascular Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fcvm.2026.1753834}
}
EUVIMED